首页> 外文OA文献 >Impact of Philadelphia chromosome‐like alterations on efficacy and safety of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukemia: a post hoc analysis from the phase 3 TOWER study

【2h】

Impact of Philadelphia chromosome‐like alterations on efficacy and safety of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukemia: a post hoc analysis from the phase 3 TOWER study

机译：染色体染色体的影响对成年人患者的白癜风疗效和安全性的影响：阶段3塔研究后的后HOC分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Elias Jabbour; Keyur Patel; Nitin Jain; Dzifa Duose; Rajyalakshmi Luthra; Nicholas J. Short; Gerhard Zugmaier; Anthony San Lucas; Kelly Velasco; Qui Tran; Faraz Zaman; Marina Konopleva; Hagop Kantarjian;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Age Subgroup Analysis of Health-Related Quality of Life of Blinatumomab Versus Standard-of-Care Chemotherapy in Patients with Relapsed or Refractory Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia in a Randomized, Open-Label, Phase 3 Study (TOWER) [J] . Topp Max S., Zimmerman Zachary F., Cannell Paul, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：年龄亚群分析健康相关的Blinatumomab患者生活质量与患有复发或难治性费城染色体阴性B细胞前体急性淋巴细胞白血病的患者的水平化疗，在随机的，开放标签，第3期研究（塔）中
2. Disease Burden Subgroup Analysis of HealthRelated Quality of Life of Blinatumomab Versus Standard-of-Care Chemotherapy in Patients with Relapsed or Refractory Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia in a Randomized, Open-Label Phase 3 Study ( TOWER) [J] . Stein Anthony S., Zimmerman Zachary F., Cannell Paul, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：疾病负担亚群分析Blinatumomab的健康生活质量与患者的复发或难治性费城染色体阴性B细胞前体急性淋巴细胞白血病在随机开放标签第3研究（塔）
3. Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study [J] . Martinelli Giovanni, Boissel Nicolas, Chevallier Patrice, Journal of Clinical Oncology . 2017,第16期

机译：成年患者的完全血液学和分子反应患者复发/难治性费城染色体阳性B-前体急性淋巴细胞白血病，后伴有BLINATUMOMAB处理：II期，单臂，多中心研究的结果
4. Analysis of Competing Endogenous RNA Network and Prediction of Prognosis in Acute Lymphoblastic Leukemia Patients of Phase II and III [C] . Jianzhi Deng, Xiaohui Cheng, Yuehan Zhou International Conference on Modelling, Simulation and Big Data Analysis . 2019

机译：竞争内源性RNA网络的分析及III期急性淋巴细胞白血病患者预后预测
5. Prognostic factors in patients with Philadelphia chromosome positive acute lymphoblastic leukemia. [D] . Faccuseh, Maria. 1999

机译：费城染色体阳性的急性淋巴细胞白血病患者的预后因素。
6. Estimating Long-Term Survival of Adults with Philadelphia Chromosome-Negative Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia Treated with Blinatumomab Using Historical Data [O] . Arie Barlev, Vincent W. Lin, Aaron Katz, -1

机译：使用历史数据估算使用Blinatumomab治疗的费城染色体阴性复发性/难治性B前体急性淋巴细胞性白血病成人的长期生存
7. Complete hematologic and molecular response in adult patients with relapsed/refractory philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia following treatment with blinatumomab: results from a phase II, single-arm, multicenter study [O] . Martinelli Giovanni, Boissel Nicolas, Chevallier Patrice, 2017

机译：成年复发/难治性费城染色体阳性B前体急性淋巴细胞白血病患者接受blinatumomab治疗后的完整血液学和分子反应：II期，单臂，多中心研究的结果

Impact of Philadelphia chromosome‐like alterations on efficacy and safety of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukemia: a post hoc analysis from the phase 3 TOWER study

著录项

引文网络

相似文献

相关主题

期刊订阅